Sandusky, OH, Oct. 13, 2021 (GLOBE NEWSWIRE) — PAO Group, Inc. (OTC Pink: PAOG) today announced encountering a flurry of outside interest of late into the company’s CBD pharmaceutical respiratory treatment research.
Last year, the company acquired intellectual property derived through research into CBD extracted in association with a patented extraction method (U.S. Patent No. 9,199,960). The ongoing research targets the treatment of respiratory disorders in support of a pharmaceutical being developed by PAOG under the name RespRx.
PAOG has engaged Veristat as a CRO to prepare an IND for the FDA.
Of late, CBD is becoming more universally recognized for is respiratory health benefits. For example:
In conjunction with PAOG’s ongoing IND initiative for RespRx, and PAOG’s connection with U.S. Patent No. 9,199,960 entitled “METHOD AND APPARATUS FOR PROCESSING,” PAOG is now receiving unsolicited contacts expressing interests ranging from investment and partnership to acquisition.
PAOG is not altering its plans at this stage in reaction to the recent interest. The company will continue developing its pharmaceutical and nutraceutical treatments.
PAOG expects to realize its first CBD nutraceutical product sales beginning imminently in Q4, 2021.
The company confirms shipping its first CBD nutraceutical product to its distribution partner, North American Cannabis Holdings, Inc. (OTC PINK: USMJ).
PAOG plans to announce specifics about its first CBD nutraceutical product in an upcoming formal product launch announcement once the distributor is set up to begin sales and distribution.
PAOG expects revenue to grow rapidly following its first CBD nutraceutical product launch as the company has follow-on products lined up to follow the first product adding to overall sales potential.
The 2020 CBD Nutraceuticals Market had an estimated value of $5.2 Billion, and it is expected to reach $16.4 Billion by 2027.
Learn more about USMJ’s e-commerce site at www.usmj.com.
Learn more about PAOG at www.paogroupinc.com.
Forward-Looking Statements: Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934 and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the company are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Technical complications, which may arise, could prevent the prompt implementation of any strategically significant plan(s) outlined above. The Company undertakes no duty to revise or update any forward-looking statements to reflect events or circumstances after the date of this release.
- Is CBD Right for Your Dog?“I am an advocate for CBD, but we succeed because our goal is to educate owners. We try to come from a place of science and personal experience. We do not believe in pressure selling CBD to anyone.”
- Opinion: It’s time for action on adult-use cannabis in PennsylvaniaNational and local surveys of voters continue to reflect overwhelming support for legalization. Cannabis consumers are no longer asking for permission, instead we are demanding REAL reform at the ballot box. Politicians who make grand promises of cannabis reform should be on notice to start making good, or start looking for jobs in the private sector.
- Virginia seals 64,000 marijuana distribution chargesOfficials said the records were scrubbed from the state’s criminal record database, which is used by employers like school boards, state agencies and local governments to screen employees.
- Charlie Crist vows to push for legalizing cannabis as governorAt a press conference in the state capital, Crist argued that the criminalization of marijuana has negatively impacted Floridians, therefore, he will push for “expungement of all existing charges and sentences for misdemeanors and third-degree felonies for marijuana possession.”
- Nevada program to help BIPOC cannabis industry applicantsNevada’s cannabis rush following the legalization of recreational and medical marijuana saw the rise of another multibillion dollar industry that is predominantly owned and managed by white men.
- Judge blocks residency rule for Missouri medical cannabis licensesA federal judge last week permanently blocked Missouri from enforcing a requirement that medical marijuana licenses go to businesses owned by residents of the state.
- SD adult-use cannabis initiative approved to gather signaturesSouth Dakotans for Better Marijuana Laws, the group behind last year’s cannabis legalization push, announced yesterday that a new initiative has been approved for signature gathering.
- Cannabis “tipping point” close, says Marijuana Policy Project headDuring a recent phone interview, Hawkins told Profiles in Legalization that he thinks half of U.S. states fully legalizing cannabis might be the “tipping point” into an end to federal cannabis prohibition.
- Virginia medical cannabis patients see high prices and long waitsJenn Michelle Pedini, executive director of Virginia NORML, the state chapter of the National Organization for the Reform Marijuana Laws, noted the state’s decision to limit the program to five producers, who are only allowed to operate in the specific region of the state in which they are licensed.
- MS activists rally around the state for medical cannabis lawsHouse and Senate negotiators dickered most of the summer on a plan to replace the medical marijuana program the high court shot down. Reeves had said that if lawmakers could reach an agreement, he would call them into special session to pass it.